'Immunity can wear off over time': Doctors highlight undervaccination in adults
Vaccinations are commonly considered a childhood health issue, but if adults think they're protected, doctors say that's not always the case. Some adults may need a vaccination booster for highly contagious infectious diseases like measles.
TTP, a technology company based in Melbourn, UK, is developing a handheld PCR (polymerase chain reaction) diagnostic device that can rapidly detect influenza viruses, and one day other viruses, in samples of nasal mucus. The company claims that the s...
Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 2019;366:599-606.
Measles may lead to serious, fatal complications not often associated with the disease, a new study finds.
(Natural News) Every time anybody in America gets the measles, the mass media go into their scripted frenzy, and the vaccine industry pushes out their propaganda via the CDC hub of lies and deception. Get the measles vaccine or catch the measles and die from the measles – that’s the message. Then CNN and WebMD...
Vincent and Rich return to the University of Texas Medical Branch at Galveston to speak with Dennis Bente, Shannan Rossi, Nikos Vasilakis, and Scott Weaver about their work on viruses transmitted by mosquitoes and ticks. Hosts: Vincent Racaniello and Rich Condit Guests: Dennis Bente, Shannan Rossi, Nikos Vasilakis, and Scott Weaver Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Measles virus vectored chikungunya vaccine (J Inf Dis) World Reference Center for Emerging Viruses and Arboviruses Insect-specific alphavirus vaccine vect...
CONCLUSION: Our results demonstrated lower than expected seroprotection against measles among vaccinated children. Understanding the factors that affect host immunity to measles will aid in developing more efficient and effective immunization programs in DRC. PMID: 32057333 [PubMed - in process]
This NIHR Signal pooled data from 56 studies and found that the vaccine is around 58% effective when administered before nine months compared with 83% after nine months.With measles on the rise in Europe and the UK, it is helpful to know that in the event of a measles outbreak, it could be used safely in younger infants as an additional measure.
This House of Lords Library Briefing focuses on the measles, mumps and rubella (MMR) jab. It looks at social media's role in the spread of misinformation, what the UK Government and social media companies have pledged to do about it, and what other countries are doing to solve declining rates of MMR vaccination.
Conclusions: Our study revealed heterogeneity across HDs' mumps outbreak responses but also identified common challenges that will inform future Centers for Disease Control and Prevention guidance. These results were considered in the October 2017 Advisory Committee on Immunization Practices recommendation for use of a third dose of MMR vaccine for persons at increased risk for mumps during an outbreak and in the development of Centers for Disease Control and Prevention guidance for HDs when applying the Advisory Committee on Immunization Practices recommendation.